Anti-cancer effects of cinnamon: Insights into its apoptosis effects.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Sep 2019
Historique:
received: 15 04 2019
revised: 24 05 2019
accepted: 24 05 2019
pubmed: 14 6 2019
medline: 30 8 2019
entrez: 14 6 2019
Statut: ppublish

Résumé

Cancer is known as a leading cause of death worldwide. In the last two decades, the incidence of cancer has been dramatically increased mostly due to lifestyle changes. The importance of this issue has attracted further attention to discover novel therapies to prevent and treat cancers. According to previous studies, drugs used to treat cancer have shown significant limitations. Therefore, the role of herbal medicines alone or in combination with chemotherapy drugs has been extensively studied in cancer treatment. Cinnamon is a natural component showing a wide range of pharmacological functions including anti-oxidant, anti-microbial and anti-cancer activities. Impaired apoptosis plays critical roles in the initiation and progression of cancer. Increasing evidence indicates that cinnamon, as a therapeutic agent, has anti-cancer effects via affecting numerous apoptosis-related pathways in cancer cells. Here, we highlighted anticancer properties of cinnamon, particularly through targeting apoptosis-related mechanisms.

Identifiants

pubmed: 31195168
pii: S0223-5234(19)30485-4
doi: 10.1016/j.ejmech.2019.05.067
pii:
doi:

Substances chimiques

2'-benzoyloxycinnamaldehyde 0
Antineoplastic Agents 0
Benzoates 0
Plant Extracts 0
Eugenol 3T8H1794QW
Acrolein 7864XYD3JJ
cinnamaldehyde SR60A3XG0F

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-140

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Sahand Sadeghi (S)

Department of Nutrition, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.

Amirhossein Davoodvandi (A)

Department of Nutrition, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran; Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran.

Mohammad Hossein Pourhanifeh (MH)

Department of Nutrition, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran; Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran.

Nasrin Sharifi (N)

Department of Nutrition, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.

Reza ArefNezhad (R)

Department of Anatomy, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Roxana Sahebnasagh (R)

Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Shirin Amiri Moghadam (SA)

Department of Community Medicine, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Amirhossein Sahebkar (A)

Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: sahebkara@mums.ac.ir.

Hamed Mirzaei (H)

Department of Nutrition, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran. Electronic address: mirzaei-h@kaums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH